French Antitrust Allows Conditional Purchase of Labexa by Cerba

The French competition authority said it will allow Cerba’s purchase of Labexa following the buyer’s decision to sell an asset.

• Cerba and Labexa are bio-medical companies with laboratories that conduct tests
• The combined entity has agreed sell a medical-examination site in Maubourguet owned by Labexa, the competition regulator said

Read complete statement here

To contact the reporter on this story:
Vidya Root in Paris at vroot@bloomberg.net

To contact the editor responsible for this story:
Vidya Root at vroot@bloomberg.net

© 2021 Bloomberg L.P. All rights reserved. Used with permission.